Skip to main content

Published locations for Pembrolizumab + rituximab boost response rates in relapsed follicular lymphoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Pembrolizumab + rituximab boost response rates in relapsed follicular lymphoma

User login

  • Reset your password
  • /content/pembrolizumab-rituximab-boost-response-rates-relapsed-follicular-lymphoma
  • /hematologynews/article/141252/indolent-lymphoma/pembrolizumab-rituximab-boost-response-rates
  • /oncologypractice/article/141252/indolent-lymphoma/pembrolizumab-rituximab-boost-response-rates
  • /hematologynews/nhlhub/article/141252/indolent-lymphoma/pembrolizumab-rituximab-boost-response-rates
  • /hematology-oncology/article/141252/indolent-lymphoma/pembrolizumab-rituximab-boost-response-rates
  • /b-cell-lymphoma-icymi/article/141252/indolent-lymphoma/pembrolizumab-rituximab-boost-response-rates